inclusion criteria: 1. informed consent must be obtained prior to participation in the study 2. adult patient ≥ 18 years old 3. severe acute respiratory syndrome coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test from respiratory tract specimen (e.g nasopharyngeal swab) 4. onset of signs and symptoms of covid19 illness ≤ 7 days prior to randomization (including but not limited to fever, cough, myalgias, fatigue, abnormal chest imaging) 5. currently hospitalized or requiring hospitalization due to covid-19 disease

inclusion criteria: 1. informed consent must be obtained prior to participation in the study 2. adult patient ≥ 18 years old 3. severe acute respiratory syndrome coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test from respiratory tract specimen (e.g nasopharyngeal swab) 4. onset of signs and symptoms of covid19 illness ≤ 7 days prior to randomization (including but not limited to fever, cough, myalgias, fatigue, abnormal chest imaging) 5. currently hospitalized or requiring hospitalization due to covid-19 disease

inclusion criteria: informed consent must be obtained prior to participation in the study adult patient ≥ 18 years old severe acute respiratory syndrome coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test from respiratory tract specimen (e.g nasopharyngeal swab) onset of signs and symptoms of covid19 illness ≤ 7 days prior to randomization (including but not limited to fever, cough, myalgias, fatigue, abnormal chest imaging) currently hospitalized or requiring hospitalization due to covid-19 disease

inclusion criteria: informed consent must be obtained prior to participation in the study adult patient ≥ 18 years old severe acute respiratory syndrome coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test from respiratory tract specimen (e.g nasopharyngeal swab) onset of signs and symptoms of covid19 illness ≤ 7 days prior to randomization (including but not limited to fever, cough, myalgias, fatigue, abnormal chest imaging) currently hospitalized or requiring hospitalization due to covid-19 disease

inclusion criteria: 1. informed consent must be obtained prior to participation in the study 2. adult patient ≥ 18 years old 3. severe acute respiratory syndrome coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test from respiratory tract specimen (e.g nasopharyngeal swab) 4. onset of signs and symptoms of covid19 illness ≤ 7 days prior to randomization (including but not limited to fever, cough, myalgias, fatigue, abnormal chest imaging) 5. currently hospitalized or requiring hospitalization due to covid-19 disease

inclusion criteria: 1. informed consent must be obtained prior to participation in the study 2. adult patient ≥ 18 years old 3. severe acute respiratory syndrome coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test from respiratory tract specimen (e.g nasopharyngeal swab) 4. onset of signs and symptoms of covid19 illness ≤ 7 days prior to randomization (including but not limited to fever, cough, myalgias, fatigue, abnormal chest imaging) 5. currently hospitalized or requiring hospitalization due to covid-19 disease